BioCentury
ARTICLE | Company News

Texas Biotech deal

June 7, 1993 7:00 AM UTC

Texas Biotechnology Corp. Texas Biotechnology Corp. has sublicensed Argatroban, a synthetic antithrombolitic derived from L-arginine, from Genentech Inc. (GNE). GNE had licensed the compound from M...